# A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

- Company: Novartis Pharmaceuticals
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT07498426

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.